Market Overview:
The global Cushing's syndrome treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of Cushing's syndrome, rising awareness about the disease, and technological advancements in the field of diagnosis and treatment. The global Cushing's syndrome treatment market is segmented on the basis of type, application, and region. On the basis of type, it is divided into glucocorticoid receptor inhibitors (GCRI), somatostatin analogs (SSA), ketoconazole HRA (Ketoconazole-HRA), and others. GCRI dominates the market owing to their high efficacy in treating Cushing's syndrome patients. On the basis of application, it is segmented into hospital pharmacies, retail pharmacies, online pharmacies,.
Product Definition:
Cushing's syndrome is a hormonal disorder caused by too much cortisol in the body. Symptoms include weight gain, increased fat around the middle, high blood pressure, and diabetes. Treatment includes medications to lower cortisol levels and surgery to remove the tumor that is causing the excess cortisol. Cushing's syndrome can lead to serious health problems if not treated.
Glucocorticoid Receptor Inhibitors:
Glucocorticoid receptor inhibitors are a new class of anti-inflammatory drugs that signal the end of immune response by inhibiting the nuclear factor kappa B (NF-kappaB) pathway. This inhibition leads to reduced inflammation and enhanced recovery from physical activity.
Somatostatin:
Somatostatin is a peptide hormone that controls the release of several hormones from the brain, gastrointestinal tract, and other organs. It is produced in response to injury or stress and helps repair the body.
Application Insights:
The global market is segmented by application into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacy held the largest share in 2017 owing to the presence of a large number of hospitals that offer pharmacotherapy services. The growing prevalence of chronic diseases such as cancer and diabetes has led to an increase in demand for pharmaceutical products which is anticipated to fuel market growth over the forecast period.
In addition, Cushing¢â‚¬â„¢s syndrome patients require longer drug therapy compared with other patients due to their sensitive skin condition caused due constipation which results in longer consultation hours at healthcare facilities thereby driving up spending on drugs globally. This trend is expected to continue over the forecast period thus fueling demand for treatment across all three segments during future years.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of industry players, favorable reimbursement policies, and increasing healthcare expenditure are some factors contributing to the growth of this regional market. In addition, rising awareness about cushing's syndrome treatment options is expected to drive demand for glucocorticoid receptor inhibitors in North America during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to an increase in healthcare spending by governments and growing awareness among end-users regarding cost-effectiveness and high availability of generic drugs for HRA products. Moreover, increasing prevalence of target diseases such as cancer & diabetes will boost demand for Cushing's syndrome treatment products leading to increased revenue generation from this region during the estimated time span (2018 - 2030).
Growth Factors:
- Increasing incidence of Cushing's Syndrome
- Growing awareness about Cushing's Syndrome and its treatment options
- Rising demand for better and more effective treatments for Cushing's Syndrome
- Availability of government funding for research on new treatments for Cushing's Syndrome
- Growing number of clinical trials being conducted on new therapies for treating Cushing's Syndrome
Scope Of The Report
Report Attributes
Report Details
Report Title
Cushing's Syndrome Treatment Market Research Report
By Type
Glucocorticoid Receptor Inhibitors, Somatostatin, Ketoconazole HRA, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Pfizer, Novartis, Bristol-Myers Squibb, Corcept Therapeutics, HRA Pharma, Ipsen Biopharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global Cushing's Syndrome Treatment Market Report Segments:
The global Cushing's Syndrome Treatment market is segmented on the basis of:
Types
Glucocorticoid Receptor Inhibitors, Somatostatin, Ketoconazole HRA, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Novartis
- Bristol-Myers Squibb
- Corcept Therapeutics
- HRA Pharma
- Ipsen Biopharmaceuticals
Highlights of The Cushing's Syndrome Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glucocorticoid Receptor Inhibitors
- Somatostatin
- Ketoconazole HRA
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cushing's Syndrome Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no specific treatment for Cushing's Syndrome, but it can be treated with medication and/or surgery. Treatment typically includes reducing the amount of cortisol in the body, usually through medication or surgery.
Some of the key players operating in the cushing's syndrome treatment market are Pfizer, Novartis, Bristol-Myers Squibb, Corcept Therapeutics, HRA Pharma, Ipsen Biopharmaceuticals.
The cushing's syndrome treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cushing's Syndrome Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cushing's Syndrome Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cushing's Syndrome Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cushing's Syndrome Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cushing's Syndrome Treatment Market Size & Forecast, 2018-2028
4.5.1 Cushing's Syndrome Treatment Market Size and Y-o-Y Growth
4.5.2 Cushing's Syndrome Treatment Market Absolute $ Opportunity
Chapter 5 Global Cushing's Syndrome Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cushing's Syndrome Treatment Market Size Forecast by Type
5.2.1 Glucocorticoid Receptor Inhibitors
5.2.2 Somatostatin
5.2.3 Ketoconazole HRA
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cushing's Syndrome Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cushing's Syndrome Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cushing's Syndrome Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cushing's Syndrome Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cushing's Syndrome Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Cushing's Syndrome Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cushing's Syndrome Treatment Market Size Forecast by Type
9.6.1 Glucocorticoid Receptor Inhibitors
9.6.2 Somatostatin
9.6.3 Ketoconazole HRA
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cushing's Syndrome Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cushing's Syndrome Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Cushing's Syndrome Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cushing's Syndrome Treatment Market Size Forecast by Type
10.6.1 Glucocorticoid Receptor Inhibitors
10.6.2 Somatostatin
10.6.3 Ketoconazole HRA
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cushing's Syndrome Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cushing's Syndrome Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cushing's Syndrome Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cushing's Syndrome Treatment Market Size Forecast by Type
11.6.1 Glucocorticoid Receptor Inhibitors
11.6.2 Somatostatin
11.6.3 Ketoconazole HRA
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cushing's Syndrome Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cushing's Syndrome Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Cushing's Syndrome Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cushing's Syndrome Treatment Market Size Forecast by Type
12.6.1 Glucocorticoid Receptor Inhibitors
12.6.2 Somatostatin
12.6.3 Ketoconazole HRA
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cushing's Syndrome Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cushing's Syndrome Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cushing's Syndrome Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cushing's Syndrome Treatment Market Size Forecast by Type
13.6.1 Glucocorticoid Receptor Inhibitors
13.6.2 Somatostatin
13.6.3 Ketoconazole HRA
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cushing's Syndrome Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cushing's Syndrome Treatment Market: Competitive Dashboard
14.2 Global Cushing's Syndrome Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Novartis
14.3.3 Bristol-Myers Squibb
14.3.4 Corcept Therapeutics
14.3.5 HRA Pharma
14.3.6 Ipsen Biopharmaceuticals
